PubMed RSS Feed - -Aspirin alleviates skin inflammation and angiogenesis in rosacea

[rss]

Int Immunopharmacol. 2021 Mar 17;95:107558. doi: 10.1016/j.intimp.2021.107558. Online ahead of print.

ABSTRACT

Rosacea is a chronic, relapsing inflammatory skin disease featured by abnormal activation of immune responses, vascular dysfunction and prominent permeability barrier alterations. Aspirin, as the first nonsteroidal anti-inflammatory drug (NSAID), is widely used for various inflammatory conditions due to its anti-inflammatory and anti-angiogenic properties. However, its effects on rosacea are unclear. In this study, we demonstrated that aspirin dramatically improved pathological phenotypes in LL37-induced rosacea-like mice. The RNA-sequencing analysis revealed that aspirin alleviated rosacea-like skin dermatitis mainly via modulating immune responses. Mechanically, we showed that aspirin decreased the production of chemokines and cytokines associated with rosacea, and suppressed the Th1- and Th17-polarized immune responses in LL37-induced rosacea-like mice. Besides, aspirin administration decreased the microvessels density and the VEGF expression in rosacea-like skin. We further demonstrated that aspirin inhibited the activation of NF-κB signaling and the release of its downstream pro-inflammatory cytokines. Collectively we showed that aspirin exerts a curative effect on rosacea by attenuating skin inflammation and angiogenesis, suggesting a promising therapeutic candidate for the treatment of rosacea.

PMID:33743316 | DOI:10.1016/j.intimp.2021.107558

{url} = URL to article

Etcetera

Angiogenesis & VEGF

Aspirin for Rosacea

Aspirin For Rosacea Flushing

Cytokines and Rosacea